Enhanced ligation reactions
AssigneeLife Technologies Corporation
InventorsStephen Hendricks, David King, Lei Xi, Marian Peris
Life of this patent
Estimating the term…
Abstract
In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends.
Claims20
A method for ligating nucleic acids comprising:
- conducting a nucleic acid ligation reaction in the presence of an agent that catalyzes removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid.
A method for sequencing comprising:
- a) hybridizing a template polynucleotide to a first and second oligonucleotide probe so that the first and second oligonucleotide probes abut each other to form a nick, wherein the second oligonucleotide probe is labeled with a distinctive detectable reporter moiety;
- b) contacting the nick with at least one aprataxin enzyme and at least one ligase enzyme to close the nick;
- and
- c) detecting the distinctive detectable reporter moiety thereby determining the sequence of the second oligonucleotide probe hybridized to the template polynucleotide.
Dependencies are inferred from the claim text.